(Q58482092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

peripheral T-cell lymphoma

29 January 2020

main subject

1 reference

based on heuristic

inferred from title

Peripheral T-cell lymphoma not otherwise specified

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lisa Argnani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Emilio Berti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Enrico Derenzini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

Stefano Pileri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Cinzia Pellegrini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Alessandro Broccoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Vittorio Stefoni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Letizia Gandolfi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Federica Quirini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Michele Baccarani

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1585-1588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Treatment of T-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.573031

10.3109/10428194.2011.573031

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21504290%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference